Onconetix, Inc. (ONCO)
NASDAQ: ONCO · Real-Time Price · USD
0.768
+0.026 (3.52%)
At close: Apr 28, 2026, 4:00 PM EDT
0.705
-0.063 (-8.21%)
After-hours: Apr 28, 2026, 7:59 PM EDT
Onconetix Market Cap
Onconetix has a market cap or net worth of $532.31 thousand as of April 28, 2026. Its market cap has decreased by -36.90% in one year.
Market Cap
532.31K
Enterprise Value
-4.64M
1-Year Change
-36.90%
Ranking
Category
Stock Price
$0.77
Market Cap Chart
Since the IPO on February 18, 2022, Onconetix's market cap has decreased from $633.29M to $532.31K, a decrease of -99.92%. That is a compound annual growth rate of -81.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 514.22K | -78.80% |
| Dec 31, 2025 | 2.43M | -53.58% |
| Dec 31, 2024 | 5.23M | 43.62% |
| Dec 29, 2023 | 3.64M | -78.62% |
| Dec 30, 2022 | 17.02M | -97.31% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bone Biologics | 2.48M |
| Silexion Therapeutics | 2.43M |
| Adial Pharmaceuticals | 2.23M |
| Propanc Biopharma | 2.16M |
| Biodexa Pharmaceuticals | 2.15M |
| Scinai Immunotherapeutics | 2.08M |
| CNS Pharmaceuticals | 1.86M |
| BiomX | 1.63M |